Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Weiru Wang

Showing results (21-30 of 91) with videos related to

Pageof 10
Sort By:
Journal of Pharmaceutical Sciences|December 31, 2020
An Approach to Bioactivity Assessment for Critical Quality Attribute Identification Based on Antibody-Antigen Complex StructureXuan Gao, Weiru Wang, Devin Tesar, et al.
Journal of Microbiology (Seoul, Korea)|March 28, 2022
The rationale and potential for using Lactobacillus in the management of periodontitisJiaqi Wang, Yingman Liu, Weiru Wang, et al.
Journal of Microbiology (Seoul, Korea)|July 27, 2022
Publisher Erratum to: The rationale and potential for using Lactobacillus in the management of periodontitisJiaqi Wang, Yingman Liu, Weiru Wang, et al.
Journal of Hazardous Materials|June 12, 2026
Secondary formation of PM<sub>2.5</sub>-bound PFAS in the Pearl River Delta, China: Field evidence and implications for precursor controlWeiru Wang, Shizhen Zhao, Lele Tian, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 26, 2022
A saturation mutagenesis screen uncovers resistant and sensitizing secondary <i>KRAS</i> mutations to clinical KRAS<sup>G12C</sup> inhibitorsSiyu Feng, Marinella G Callow, Jean-Philippe Fortin, et al.
Science Signaling|August 7, 2014
Dimerization of the kinase ARAF promotes MAPK pathway activation and cell migrationJuliane Mooz, Tripat Kaur Oberoi-Khanuja, Gregory S Harms, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 16, 2018
ERK Mutations and Amplification Confer Resistance to ERK-Inhibitor TherapyBijay S Jaiswal, Steffen Durinck, Eric W Stawiski, et al.
Journal of Molecular Biology|June 8, 2002
Structural characterization of the reaction pathway in phosphoserine phosphatase: crystallographic "snapshots" of intermediate statesWeiru Wang, Ho S Cho, Rosalind Kim, et al.
Chembiochem : a European Journal of Chemical Biology|May 7, 2014
Structural and biochemical analyses of the catalysis and potency impact of inhibitor phosphoribosylation by human nicotinamide phosphoribosyltransferaseAngela Oh, Yen-Ching Ho, Mark Zak, et al.
Bioorganic & Medicinal Chemistry Letters|September 5, 2015
Fragment-based discovery of potent ERK2 pyrrolopyrazine inhibitorsDaniel J Burdick, Shumei Wang, Christopher Heise, et al.
Pageof 10

Showing results (21-30 of 91) with videos related to

Sort By:
Pageof 10
Journal of Pharmaceutical Sciences|December 31, 2020
An Approach to Bioactivity Assessment for Critical Quality Attribute Identification Based on Antibody-Antigen Complex StructureXuan Gao, Weiru Wang, Devin Tesar, et al.
Journal of Microbiology (Seoul, Korea)|March 28, 2022
The rationale and potential for using Lactobacillus in the management of periodontitisJiaqi Wang, Yingman Liu, Weiru Wang, et al.
Journal of Microbiology (Seoul, Korea)|July 27, 2022
Publisher Erratum to: The rationale and potential for using Lactobacillus in the management of periodontitisJiaqi Wang, Yingman Liu, Weiru Wang, et al.
Journal of Hazardous Materials|June 12, 2026
Secondary formation of PM<sub>2.5</sub>-bound PFAS in the Pearl River Delta, China: Field evidence and implications for precursor controlWeiru Wang, Shizhen Zhao, Lele Tian, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 26, 2022
A saturation mutagenesis screen uncovers resistant and sensitizing secondary <i>KRAS</i> mutations to clinical KRAS<sup>G12C</sup> inhibitorsSiyu Feng, Marinella G Callow, Jean-Philippe Fortin, et al.
Science Signaling|August 7, 2014
Dimerization of the kinase ARAF promotes MAPK pathway activation and cell migrationJuliane Mooz, Tripat Kaur Oberoi-Khanuja, Gregory S Harms, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 16, 2018
ERK Mutations and Amplification Confer Resistance to ERK-Inhibitor TherapyBijay S Jaiswal, Steffen Durinck, Eric W Stawiski, et al.
Journal of Molecular Biology|June 8, 2002
Structural characterization of the reaction pathway in phosphoserine phosphatase: crystallographic "snapshots" of intermediate statesWeiru Wang, Ho S Cho, Rosalind Kim, et al.
Chembiochem : a European Journal of Chemical Biology|May 7, 2014
Structural and biochemical analyses of the catalysis and potency impact of inhibitor phosphoribosylation by human nicotinamide phosphoribosyltransferaseAngela Oh, Yen-Ching Ho, Mark Zak, et al.
Bioorganic & Medicinal Chemistry Letters|September 5, 2015
Fragment-based discovery of potent ERK2 pyrrolopyrazine inhibitorsDaniel J Burdick, Shumei Wang, Christopher Heise, et al.
Pageof 10